Clinical Trial Update: Efficacy and Safety Study of VB-1953 Topical Gel for Inflammatory Facial Acne Vulgaris [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for VB-1953 topical gel in inflammatory facial acne vulgaris evaluating efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• VB-1953 topical gel (VB-1953)

Snippet

Sponsor: Vyome Therapeutics Inc. | Conditions: Acne Vulgaris | Phase 2 | Status: UNKNOWN